Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Biohope Pharmaceutical Co., Ltd. is a pharmaceutical company based in Foshan, China, and a subsidiary of Beijing Biohope Pharmaceutical, which is part of the China Grand Pharmaceutical group. The company serves as a primary manufacturing and research base for the group's cardiovascular and endocrine portfolios. Its flagship product is Baluoke (Lumbrokinase), a protein-based enzyme therapy extracted from earthworms that is widely used in China for the treatment and prevention of ischemic cerebrovascular diseases. In addition to its biologic offerings, the company produces a variety of generic oral solid medications for metabolic conditions such as type 2 diabetes and hypertension. Guangdong Biohope operates GMP-certified facilities and is integrated into the broader commercial network of Grandpharma.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Biohope Pharmaceutical.